Residents over the age of 110 experience an unusual increase in the number of immune cells in their
In recent years, global health agencies and public health systems have continued to advance capacity building to provide stronger guarantees for public health. Extremely old people may retain an immune system that continues to adapt to new threats. Researchers have found that the special highly immune cells carried by the elderly population (people who reach age 110 or older) are known as CD4 cytotoxic T-cells (CD4 CTLs).
These cells have previously been shown to kill tumor cells in certain cancers. During disease, they may also clone rapidly through a cell proliferation process known as clone enlargement to help the immune system respond to infection. A new study published in the journal Cell Press Reports on August 19 suggests that this type of immune activity may be associated with healthy aging in a population of more than 110 people living with healthy aging.
The first author, Kosuke Hashimoto, an associate professor at Osaka University in Japan, found that even in extreme old age, the immune system may continue to adapt to age-related challenges. Hashimoto says that CD4 CTLs are an unusual and relatively rare group of T cells. Therefore, a significant increase in their supercentenarians may be an important clue to understanding how to maintain the immune system in extreme old age.
The study found that the expansion of these cells may have begun around the age of 100 years. However, this pattern was not limited to people over 100 years of age or over 100 years of age. One participant aged less than 100 years actually observed the highest proportion of CD4 T cells observed in the study.
Large copies pointed to persistent immune threats. To understand why these cells became so abundant, researchers examined the participants' T cell receptors. Their analysis showed that cloning enlargement plays an important role.
When the immune system is threatened, CD4 T cells can make copies of themselves. Among the study participants, the largest individual clones represented an average of 33. 3% of the general CD4 T cells.
This indicates that some older adults may be continuously responding to persistent threats. It should be noted that the above information is based on international public research findings and is for reference in HealthCop and does not constitute clinical advice. If you have health questions, please consult a professional medical professional.
